Clofibrate-induced low density lipoprotein elevation therapeutic implications and treatment by colestipol resin
- 1 May 1976
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 23 (3) , 413-427
- https://doi.org/10.1016/0021-9150(76)90003-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Combined hyperlipoproteinemia Evidence for a new lipoprotein phenotypeAtherosclerosis, 1974
- On the metabolic conversion of human plasma very low density lipoprotein to low density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Type IV hyperlipoproteinemia. Clofibrate without dietary therapyPublished by American Medical Association (AMA) ,1972
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972
- CHANGE OF LIPOPROTEIN PATTERN BY CLOFIBRATE IN HYPERGLYCERIDAEMIA AND MIXED HYPERLIPIDAEMIAActa Medica Scandinavica, 1972
- Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in ManCirculation, 1969
- Treatment of hyperlipidemiasThe American Journal of Medicine, 1968
- Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyiso-butyrate administrationClinica Chimica Acta; International Journal of Clinical Chemistry, 1968
- EditorialCirculation, 1965